142 related articles for article (PubMed ID: 6111093)
21. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
Müller MJ; Regenbogen B; Härtter S; Eich FX; Hiemke C
J Psychiatr Res; 2007 Oct; 41(8):673-9. PubMed ID: 16324716
[TBL] [Abstract][Full Text] [Related]
22. Basal and stimulated levels of prolactin, TSH, and LH in serum of chronic schizophrenic patients long-term treated with neuroleptics: relations to psychopathology.
Naber D; Ackenheil M; Laakmann G
Adv Biochem Psychopharmacol; 1980; 24():419-23. PubMed ID: 6105792
[TBL] [Abstract][Full Text] [Related]
23. Tardive dyskinesia: clinical and neuroendocrine response to low dose bromocriptine.
Lenox RH; Weaver LA; Saran BM
J Clin Psychopharmacol; 1985 Oct; 5(5):286-92. PubMed ID: 4044881
[TBL] [Abstract][Full Text] [Related]
24. Prolactin levels and effects of neuroleptics.
Brown WA
Psychosomatics; 1983 Jun; 24(6):569-74, 577-81. PubMed ID: 6136065
[No Abstract] [Full Text] [Related]
25. Bromocriptine therapy in chronic schizophrenia: effects on symptomatology, sleep patterns, and prolactin response to stimulation.
Brambilla F; Scarone S; Pugnetti L; Massironi R; Penati G; Nobile P
Psychiatry Res; 1983 Mar; 8(3):159-69. PubMed ID: 6574535
[TBL] [Abstract][Full Text] [Related]
26. Failure of pyridoxine to effect neuroleptic-induced hyperprolactinemia in psychotic patients.
Brambilla F; Penati G; Freni S; Bottinelli S; Maffei C; Maiella V
J Endocrinol Invest; 1979; 2(3):299-302. PubMed ID: 43342
[TBL] [Abstract][Full Text] [Related]
27. [Difference in prolaction response of schizophrenic patients to equivalent doses of haloperidol, remoxipride and sulpiride].
Liu KL; Lung FW
Kaohsiung J Med Sci; 1996 Dec; 12(12):685-90. PubMed ID: 9011126
[TBL] [Abstract][Full Text] [Related]
28. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
[TBL] [Abstract][Full Text] [Related]
29. Effect of clozapine on human serum prolactin levels.
Meltzer HY; Goode DJ; Schyve PM; Young M; Fang VS
Am J Psychiatry; 1979 Dec; 136(12):1550-5. PubMed ID: 507205
[TBL] [Abstract][Full Text] [Related]
30. Tolerance to the prolactin-elevating effect of neuroleptics.
Brown WA; Laughren TP
Psychiatry Res; 1981 Dec; 5(3):317-22. PubMed ID: 6119716
[TBL] [Abstract][Full Text] [Related]
31. Selegiline for neuroleptic-induced parkinsonism.
Gewirtz GR; Sharif Z; Cadet JL; Sarti P; Gorman JM
Pharmacopsychiatry; 1993 Jul; 26(4):128-9. PubMed ID: 7901857
[No Abstract] [Full Text] [Related]
32. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
Chouinard G; Annable L; Jones BD; Collu R
Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
[TBL] [Abstract][Full Text] [Related]
34. Radio receptor assay of serum neuroleptic levels in psychiatric patients.
Krska J; Sampath G; Shah A; Soni SD
Br J Psychiatry; 1986 Feb; 148():187-93. PubMed ID: 2870755
[TBL] [Abstract][Full Text] [Related]
35. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge.
Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M
Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731
[TBL] [Abstract][Full Text] [Related]
36. Importance of akinesia: plasma chlorpromazine and prolactin levels.
Van Putten T; May PR; Wilkins JN
Am J Psychiatry; 1980 Nov; 137(11):1446-8. PubMed ID: 7435684
[TBL] [Abstract][Full Text] [Related]
37. Therapy of extrapyramidal side effects, with particular reference to persistent dyskinesia and lithium tremor.
Pöldinger W
Int Pharmacopsychiatry; 1978; 13(4):230-3. PubMed ID: 32149
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels.
Mielke DH; Gallant DM; Kessler C
Am J Psychiatry; 1977 Dec; 134(12):1371-5. PubMed ID: 21571
[TBL] [Abstract][Full Text] [Related]
39. [Main side effects of the use of neuroleptics].
Morato GS; Takahashi RN
AMB Rev Assoc Med Bras; 1982; 28(11-12):247-9. PubMed ID: 6133319
[No Abstract] [Full Text] [Related]
40. [Neuroleptic malignant syndrome. Efficacy of bromocriptine].
Azorin JM; Bouchacourt M; Lavergne T; Giudicelli S
Presse Med; 1984 Jun; 13(27):1702. PubMed ID: 6146134
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
